Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer.
Chong IY, Aronson L, Bryant H, Gulati A, Campbell J, Elliott R, Pettitt S, Wilkerson P, Lambros MB, Reis-Filho JS, Ramessur A, Davidson M, Chau I, Cunningham D, Ashworth A, Lord CJ.
Chong IY, et al. Among authors: davidson m.
Gut. 2018 Oct;67(10):1780-1792. doi: 10.1136/gutjnl-2017-314408. Epub 2017 Aug 22.
Gut. 2018.
PMID: 28830912
Free PMC article.